# Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM

> **NCT00515801** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 18 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** glibenclamide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00515801
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515801, "Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00515801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*